Cargando…
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
BACKGROUND: Sarcomas is a group of heterogeneous malignant tumors originated from mesenchymal tissue and different types of sarcomas have disparate outcomes. The present study aims to identify the prognostic value of immune-related genes (IRGs) in sarcoma and establish a prognostic signature based o...
Autores principales: | Shen, Rui, Liu, Bo, Li, Xuesen, Yu, Tengbo, Xu, Kuishuai, Ma, Jinfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871579/ https://www.ncbi.nlm.nih.gov/pubmed/33557781 http://dx.doi.org/10.1186/s12885-021-07852-2 |
Ejemplares similares
-
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
por: Bertucci, Francois, et al.
Publicado: (2022) -
Development of a radiosensitivity gene signature for patients with soft tissue sarcoma
por: Tang, Zaixiang, et al.
Publicado: (2017) -
Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden
por: Raj, Shailaja K. S., et al.
Publicado: (2022) -
Identification and Validation of Pyroptosis-Related lncRNA Signature and Its Correlation with Immune Landscape in Soft Tissue Sarcomas
por: Lin, Zhengjun, et al.
Publicado: (2021) -
Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2017)